KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brinks (BCO) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Brinks (BCO) over the last 17 years, with Q3 2025 value amounting to $3.4 million.

  • Brinks' Asset Writedowns and Impairment rose 14285.71% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 2777.78%. This contributed to the annual value of $4.8 million for FY2024, which is 5339.81% down from last year.
  • As of Q3 2025, Brinks' Asset Writedowns and Impairment stood at $3.4 million, which was up 14285.71% from $400000.0 recorded in Q2 2025.
  • In the past 5 years, Brinks' Asset Writedowns and Impairment ranged from a high of $5.0 million in Q3 2021 and a low of $400000.0 during Q2 2025
  • Its 5-year average for Asset Writedowns and Impairment is $2.1 million, with a median of $1.5 million in 2023.
  • In the last 5 years, Brinks' Asset Writedowns and Impairment crashed by 8648.65% in 2024 and then surged by 22000.0% in 2025.
  • Brinks' Asset Writedowns and Impairment (Quarter) stood at $2.0 million in 2021, then tumbled by 45.0% to $1.1 million in 2022, then soared by 90.91% to $2.1 million in 2023, then fell by 28.57% to $1.5 million in 2024, then surged by 126.67% to $3.4 million in 2025.
  • Its Asset Writedowns and Impairment stands at $3.4 million for Q3 2025, versus $400000.0 for Q2 2025 and $1.6 million for Q1 2025.